» Articles » PMID: 36505599

Body-mass Index COVID-19 Severity: A Systematic Review of Systematic Reviews

Overview
Specialty Public Health
Date 2022 Dec 12
PMID 36505599
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Conflicting studies have resulted in several systematic reviews and meta-analyses on the relationship between COVID-19 and body mass index (BMI).

Methods: This systematic review of systematic reviews followed an umbrella review design, and preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines; Medical literature analysis and retrieval system online (MEDLINE) and SCOPUS databases were searched for systematic reviews on the topic. A predefined screening and selection procedure was done for the retrieved results based on the population, intervention/interest, comparator, outcome, study (PICOS) framework.

Results: The search strategy yielded 6334 citations. With the predefined selection and screening process, 23 systematic reviews were retrieved for inclusion in the present study. Twenty-three ( = 23) systematic reviews met the inclusion criteria. As expected, there was overlap across the reviews in the included primary studies. Available evidence suggests that Class III obesity (morbid obesity) is strongly associated with increased mortality risk in patients with Covid-19. It is difficult to draw a firm conclusion about Class I and Class II obesity due to conflicting outcomes of metanalyses. Increased obesity was consistently associated with increased risk of invasive mechanical ventilation (IMV) in all the reviews with low to moderate heterogeneity.

Conclusions: Available evidence suggests that Class III obesity (morbid obesity) is strongly associated with increased mortality risk in patients with Covid-19. Increased BMI is positively associated with the risk of IMV and the severity of COVID- care.

Citing Articles

Efficient clinical decision-making process via AI-based multimodal data fusion: A COVID-19 case study.

Moris D, de Moura J, Marcos P, Miguez Rey E, Novo J, Ortega M Heliyon. 2024; 10(20):e38642.

PMID: 39640748 PMC: 11619951. DOI: 10.1016/j.heliyon.2024.e38642.


Association of body mass index with long-term outcomes in older adults hospitalized for COVID-19: an observational study.

Putot A, Guyot C, Manckoundia P, Wymelbeke-Delannoy V Sci Rep. 2024; 14(1):7512.

PMID: 38553629 PMC: 10980698. DOI: 10.1038/s41598-024-58388-x.


Diabetes Mellitus, Energy Metabolism, and COVID-19.

Conte C, Cipponeri E, Roden M Endocr Rev. 2023; 45(2):281-308.

PMID: 37934800 PMC: 10911957. DOI: 10.1210/endrev/bnad032.

References
1.
Ho J, Fernando D, Chan M, Sia C . Obesity in COVID-19: A Systematic Review and Meta-analysis. Ann Acad Med Singap. 2021; 49(12):996-1008. View

2.
Soeroto A, Soetedjo N, Purwiga A, Santoso P, Kulsum I, Suryadinata H . Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis. Diabetes Metab Syndr. 2020; 14(6):1897-1904. PMC: 7521380. DOI: 10.1016/j.dsx.2020.09.029. View

3.
Yang J, Tian C, Chen Y, Zhu C, Chi H, Li J . Obesity aggravates COVID-19: An updated systematic review and meta-analysis. J Med Virol. 2020; 93(5):2662-2674. PMC: 7753795. DOI: 10.1002/jmv.26677. View

4.
Pal R, Banerjee M, Yadav U, Bhattacharjee S . Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature. Diabetes Metab Syndr. 2020; 14(6):1563-1569. PMC: 7434433. DOI: 10.1016/j.dsx.2020.08.015. View

5.
Tamara A, Tahapary D . Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab Syndr. 2020; 14(4):655-659. PMC: 7217103. DOI: 10.1016/j.dsx.2020.05.020. View